Omnipaque 70 and Compartment syndrome - a phase IV clinical study of FDA data

Summary:

Compartment syndrome is reported only by a few people who take Omnipaque 70.

The phase IV clinical study analyzes which people take Omnipaque 70 and have Compartment syndrome. It is created by eHealthMe based on reports of 145 people who have side effects while taking Omnipaque 70 from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 16, 2022

145 people reported to have side effects when taking Omnipaque 70.
Among them, 2 people (1.38%) have Compartment syndrome.


What is Omnipaque 70?

Omnipaque 70 has active ingredients of iohexol. eHealthMe is studying from 147 Omnipaque 70 users for its effectiveness, alternative drugs and more.

What is Compartment syndrome?

Compartment syndrome (painful condition that occurs when pressure within the muscles builds to dangerous levels) is found to be associated with 737 drugs and 385 conditions by eHealthMe.

Number of Omnipaque 70 and Compartment syndrome reports submitted per year:

Could Omnipaque 70 cause Compartment syndrome?

Time on Omnipaque 70 when people have Compartment syndrome *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Compartment syndrome when taking Omnipaque 70 *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Compartment syndrome when taking Omnipaque 70 *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common side effects people have besides Compartment syndrome *:

  1. Infusion Site Extravasation (flow of (blood or lymph) from infusion site): 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Omnipaque 70 and have Compartment syndrome?

Check whether Compartment syndrome is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Compartment syndrome and when was it recovered:

Expand to all the drugs that have ingredients of iohexol:

Alternative drugs to, pros and cons of Omnipaque 70:

Compartment syndrome treatments and more:

COVID vaccines that are related to Compartment syndrome:

Common drugs associated with Compartment syndrome:

All the drugs that are associated with Compartment syndrome:

Common conditions associated with Compartment syndrome:

All the conditions that are associated with Compartment syndrome:

How the study uses the data?

The study uses data from the FDA. It is based on iohexol (the active ingredients of Omnipaque 70) and Omnipaque 70 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: